DSM-Firmenich AG Total Liabilities

Latest as of December 2025: €10.92 Billion EUR ≈ $12.77 Billion USD

DSM-Firmenich AG total liabilities. Based on the latest financial reports, DSM-Firmenich AG (DSFIR) has total liabilities worth €10.92 Billion EUR (≈ $12.77 Billion USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check DSFIR financial resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of DSM-Firmenich AG (2013–2025)

Total liabilities of DSM-Firmenich AG from 2013 to 2025. This chart illustrates how DSM-Firmenich AG's total liabilities have evolved over time, based on quarterly financial data.

DSM-Firmenich AG Competitors by Total Liabilities

The table below lists competitors of DSM-Firmenich AG ranked by their total liabilities.

Company Country Total Liabilities
Banco De Chile
NYSE:BCH
USA $48.30 Trillion
Banco do Brasil S.A.
SA:BBAS3
Brazil R$2.35 Trillion
COCA COLA HBC AG ADRS
F:CCKC
Germany €7.66 Billion
AIB Group PLC
IR:A5G
Ireland €129.99 Billion
Solar Industries India Limited
NSE:SOLARINDS
India Rs-65.49 Billion
Snap-On Inc
NYSE:SNA
USA $2.57 Billion
Centrais Elétricas Brasileiras S.A. - Eletrobrás
SA:AXIA3
Brazil R$156.60 Billion
Wistron Corp
TW:3231
Taiwan NT$733.57 Billion

Liability Composition Analysis (2013–2025)

This chart breaks down DSM-Firmenich AG's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is DSM-Firmenich AG's balance sheet.

Liquidity & Leverage Metrics

DSM-Firmenich AG Total Liabilities Ratios Explained

DSM-Firmenich AG total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 1.59 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.60 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.37 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how DSM-Firmenich AG's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for DSM-Firmenich AG (2013–2025)

The table below shows the annual total liabilities of DSM-Firmenich AG from 2013 to 2025.

Year Total Liabilities Change
2025-12-31 €10.92 Billion
≈ $12.77 Billion
-1.16%
2024-12-31 €11.05 Billion
≈ $12.92 Billion
-1.34%
2023-12-31 €11.20 Billion
≈ $13.09 Billion
+70.78%
2022-12-31 €6.56 Billion
≈ $7.67 Billion
-0.98%
2021-12-31 €6.62 Billion
≈ $7.74 Billion
-3.44%
2020-12-31 €6.86 Billion
≈ $8.02 Billion
+22.31%
2019-12-31 €5.61 Billion
≈ $6.56 Billion
-3.74%
2018-12-31 €5.83 Billion
≈ $6.81 Billion
+1.55%
2017-12-31 €5.74 Billion
≈ $6.71 Billion
-15.36%
2016-12-31 €6.78 Billion
≈ $7.92 Billion
+10.90%
2015-12-31 €6.11 Billion
≈ $7.15 Billion
-1.26%
2014-12-31 €6.19 Billion
≈ $7.24 Billion
+6.67%
2013-12-31 €5.80 Billion
≈ $6.78 Billion
--

About DSM-Firmenich AG

AS:DSFIR Netherlands Specialty Chemicals
Market Cap
$31.66 Billion
€27.08 Billion EUR
Market Cap Rank
#1341 Global
#13 in Netherlands
Share Price
€106.75
Change (1 day)
+0.33%
52-Week Range
€55.42 - €109.75
All Time High
€123.65
About

DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. The company operates through four segments: Perfumery & Beauty; Taste, Texture & Health; Health, Nutrition & Care; and Animal Nutrition & Health. The Perfumery & Beauty creates scents using natural, sy… Read more